INNPF OTC
INNOCAN PHARMA Corp
1W: -20.0%
1M: -5.4%
3M: -68.2%
YTD: -80.6%
1Y: -80.8%
3Y: -88.5%
5Y: -94.7%
$1.40
-0.22 (-13.58%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
No convergence signal
Key Statistics
Market Cap$6.3M
52W Range1.4-14.26
Volume114
Avg Volume69
Beta-0.22
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOIris Bincovich
Employees11
SectorHealthcare
IndustryMedical - Pharmaceuticals
IPO Date2020-11-27
Websiteinnocanpharma.com
1015, 926 â 5 Avenue SW
Calgary, AB T2P 0N7
CA
Calgary, AB T2P 0N7
CA
403 777 1519
About INNOCAN PHARMA Corp
InnoCan Pharma Corporation is a pharmaceutical enterprise dedicated to innovating drug delivery systems by integrating cannabidiol (CBD) with diverse pharmaceutical ingredients. Its operations extend across the United States, Poland, France, and other international markets. The company actively pursues research and development into CBD-loaded exosomes for treating conditions like COVID-19, as well as advancing CBD-infused liposomes. InnoCan Pharma also commercializes a range of branded CBD-integrated pharmaceutical and topical treatment products, such as CBD eye serum, face oil, face cream, facial serum, sleeping mask, recovery lotion, and the Relief & Go spray. Established in 2018, the corporation is headquartered in Calgary, Canada.
Latest News
Innocan Pharma announces up to C$1M private placement of units
Innocan Pharma Announces Private Placement of Units
Innocan Pharma Posts Strong Q1 2026 Results*, With Revenue Surging 29.7% to US$6.47M
Innocan Pharma reports FY results
Innocan Pharma Reports 2025 Financial Results, with Revenues at US $26.6M
Recent Insider Trades
No insider trades found